Hydroxyprogesterone heptanoate benzilic acid hydrazone explained

Hydroxyprogesterone heptanoate benzilic acid hydrazone (OHPHBH), also known as 17α-hydroxyprogesterone 17α-heptanoate 3-benzilic acid hydrazone, is a progestin medication which was never marketed.^{[1] [2]} It is the C3 benzilic acid hydrazone of hydroxyprogesterone heptanoate (OHPH). The medication has a longer duration of action than OHPH when administered by subcutaneous injection in animals.

See also

• Testosterone enantate benzilic acid hydrazone
• List of progestogen esters § Esters of 17α-hydroxyprogesterone derivatives

Notes and References

1. Book: Ralph I. Dorfman. Bioassay. 3 February 2016. Elsevier. 978-1-4832-7276-4. 252–.
2. Gleason CH, Parker JM. The duration of activity of the benziloyl hydrazones of testosterone-17-heptanoate, estrone-3-heptanoate and 17α-hydroxy-progesterone-17-heptanoate. Endocrinology. 65. 3. 1959. 508–511. 0013-7227. 13828402. 10.1210/endo-65-3-508.